During the past decade, University of Michigan Health System: Department of Internal Medicine, Division of Rheumatology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Michigan Health System: Department of Internal Medicine, Division of Rheumatology" #1 collaborator was "Autoimmunity Centers of Excellence" with 2 trials as a collaborator, "Immune Tolerance Network (ITN)" with 2 trials as a collaborator, "Rho Federal Systems Division, Inc." with 2 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Seagen Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "University of Michigan Health System: Department of Internal Medicine, Division of Rheumatology" are "Cutaneous Lupus" (1 trials), "Diffuse Cutaneous Systemic Sclerosis" (1 trials), "Healthy Participants" (1 trials), "Juvenile Dermatomyositis (JDM)" (1 trials) and "Juvenile Idiopathic Arthritis (JIA)" (1 trials). Many other conditions were trialed in "University of Michigan Health System: Department of Internal Medicine, Division of Rheumatology" in a lesser frequency.

Most popular intervention types in "University of Michigan Health System: Department of Internal Medicine, Division of Rheumatology" are "Drug" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ad26.COV2.S" (1 trials), "BNT162b2" (1 trials), "BNT162b2, Bivalent" (1 trials), "Brentuximab Vedotin" (1 trials) and "Continue IS (B cell depletion therapy)" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Michigan Health System: Department of Internal Medicine, Division of Rheumatology" are 5 trials for "All" genders.

Currently, there are NaN active trials in "University of Michigan Health System: Department of Internal Medicine, Division of Rheumatology". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University of Michigan Health System: Department of Internal Medicine, Division of Rheumatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Michigan Health System: Department of Internal Medicine, Division of Rheumatology, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".